Skip to main content

Select Drug Profiles

FDA Approvals, In the News, Select Drug Profiles

FDA Approves First Blood Test to Detect Gene Mutation Associated with Non–Small-Cell Lung Cancer

FDA Approvals, In the News, Select Drug Profiles

FDA Approves New Diagnostic Imaging Agent to Detect Rare Neuroendocrine Tumors

FDA Approvals, Select Drug Profiles

Atezolizumab First PD-L1 Inhibitor Approved by the FDA for Advanced or Metastatic Urothelial Cancer

Lilly Ostrovsky

FDA Approvals, In the News, Select Drug Profiles

Venclexta FDA Approved for Patients with CLL

FDA Approvals, In the News, Select Drug Profiles

FDA Approves Infliximab Biosimilar for Multiple Indications

FDA Approvals, In the News, Select Drug Profiles

FDA Expands Use of Xalkori to Treat Rare Form of Advanced Non-Small Cell Lung Cancer

FDA Approvals, In the News, Select Drug Profiles

FDA Approves First Treatment for Rare Disease in Patients Who Receive Stem Cell Transplant from Blood or Bone Marrow

FDA Approvals, In the News, Select Drug Profiles

FDA Approves First Coagulation Factor-Albumin Fusion Protein to Treat Patients with Hemophilia B

FDA Approvals, In the News, Select Drug Profiles

FDA Approves Integra Omnigraft Dermal Regeneration Matrix to Treat Diabetic Foot Ulcers

Drug Updates, FDA Approvals, Select Drug Profiles

Onivyde (Irinotecan Liposome Injection) a New Treatment Option for Patients with Metastatic Pancreatic Cancer

7
8
9
10
11
12
13

Page 10 of 13
Results 91 - 100 of 121